A clinical trial of the world's first mRNA lung cancer vaccine has been started in the UK. Experts stated it as a revolutionary advancement in the treatment of lung cancer.A 67-year-old UK resident has become the first person to take this vaccine.The phase 1 clinical trial has commenced at 34 research sites across seven countries: the UK, the US, Germany, Hungary, Poland, Spain, and Turkey.Additionally, University College London Hospitals NHS Foundation Trust in the UK will conduct a trial with...
Learn More